FCGR3A and neoplasm: Meanwhile, comparison between the cytotoxicity of CD16+ NK cells vs. CD16- NK cells under the effect of BK1 proved that BK1 could only act through CD16+ NK cells to exert its anti-tumor function (Figures S4A-C).